| Financial Year |
March 31 2023 |
| Monetary Funds |
2,748,545,840.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
8,632,312.09 |
| Accounts Receivable |
1,666,251,787.61 |
| Advances to Suppliers |
351,384,561.62 |
| Other Receivables |
357,819,894.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
409,920.00 |
| Inventories |
225,645,616.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
101,754,945.00 |
| Other Current Assets |
412,158,959.79 |
| Total Current Assets |
8,825,730,199.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
237,848,703.28 |
| Long-term Equity Investment |
412,390,966.58 |
| Investment Properties |
155,224.65 |
| Fixed Assetes |
331,087,568.02 |
| Under-construction Projects |
2,313,648.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
329,472,325.73 |
| R&D expenses |
-- |
| Goodwill |
1,192,772.57 |
| Long-Term Deferred and Prepaid Expenses |
6,712,187.32 |
| Deferred Income Tax Assets |
140,654,025.12 |
| Other Non-Current Assets |
6,129,532,306.41 |
| Sub-Total of Non-Current Assets |
8,141,580,460.45 |
| Total Assets |
16,967,310,660.20 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
449,379,610.95 |
| Accounts Payable |
2,991,627,053.95 |
| Accounts Received In Advance |
2,396,258.16 |
| Employee Compensation Payable |
78,167,262.69 |
| Taxes Payable |
22,979,634.26 |
| Interest Payable |
4,244,953.88 |
| Dividend Payable |
5,504,159.30 |
| Other payables |
519,647,749.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
442,052,381.98 |
| Other Current Liabilities |
215,801,997.56 |
| Sub-Total of Current Liabilities |
7,726,525,770.51 |
| Long-term Loans |
3,948,354,760.05 |
| Bonds Payable |
774,617,469.36 |
| Long-Term Accounts Payable |
51,657.93 |
| Special Payable |
-- |
| Estimatied Liabilities |
47,061,389.47 |
| Deferred Income Tax Liabilities |
4,913,017.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,780,201,444.51 |
| Total Liabilities |
12,506,727,215.02 |
| Paid-In Capital(Or Share Stock) |
645,056,973.00 |
| Capital Surplus |
731,307,635.93 |
| Surplus Reserve |
167,962,482.10 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,313,340,814.76 |
| Minority Stockholder's Interest |
1,401,124,434.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,059,459,010.77 |
| Owner's Equity（Stockholder's Equity） |
4,460,583,445.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,967,310,660.20 |
